SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 74 filers reported holding SYNDAX PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $45,000 | +2.3% | 2,000 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $44,000 | +46.7% | 2,000 | 0.0% | 0.00% | +33.3% |
Q3 2020 | $30,000 | 0.0% | 2,000 | 0.0% | 0.00% | -25.0% |
Q2 2020 | $30,000 | +36.4% | 2,000 | 0.0% | 0.00% | +33.3% |
Q1 2020 | $22,000 | +22.2% | 2,000 | 0.0% | 0.00% | +50.0% |
Q4 2019 | $18,000 | +20.0% | 2,000 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $15,000 | -21.1% | 2,000 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $19,000 | +72.7% | 2,000 | 0.0% | 0.00% | +100.0% |
Q1 2019 | $11,000 | +22.2% | 2,000 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $9,000 | – | 2,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EXCHANGE TRADED CONCEPTS, LLC | 8,076 | $174,522 | 0.01% |
MASSMUTUAL TRUST CO FSB/ADV | 46 | $994 | 0.00% |